Replies to post #220918 on Biotech Values

[Titan V]

best efficacy. new leader in NASH space. $VKTX

best efficacy. new leader in NASH space. $VKTX https://t.co/j2BP0QKL4n

— avidresearch (@avidresearch) September 18, 2018

$VKTX 67% of pts saw liver fat cut in half

https://twitter.com/gcbioinv/status/1042023557172260864

MDGL -14% on the news.

[jbog]

It looks like Ligand is benefiting from from Vikings success today.

[Whalatane]

VKTX Titan ...On a quick glance it looks like good data to me ..better then I expected .
I assume you're long VKTX ...if so congratulations . I still have a small position in MDGL that I'll probably just keep until I've had more time to go over the data of both
Kiwi